Clinical Trial Update: Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 trial update on maintenance of efficacy for extended-release guanfacine hydrochloride in children and adolescents with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• extended-release guanfacine hydrochloride (guanfacine hydrochloride)

Snippet

Sponsor: Shire | Conditions: Attention-deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-06-09